NewLink Genetics (NLNK) Tops Q1 EPS by 6c

Go back to NewLink Genetics (NLNK) Tops Q1 EPS by 6c

NewLink Genetics (NLNK) Names Matthew L. Sherman to Board

May 1, 2018 9:04 AM EDT

NewLink Genetics Corporation (NASDAQ: NLNK) today announced the appointment of Matthew L. Sherman, M.D. to the Company's Board of Directors. In connection with this appointment, the Company's Board will be comprised of eight directors.

"We welcome Dr. Sherman to our Board of Directors," said Charles J. Link, Jr, MD, Chairman and Chief Executive Officer. His extensive experience in both clinical... More